linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Shareholdings  
Jagsonpal Pharmaceuticals Ltd.
 
BSE Code 507789
ISIN Demat INE048B01035
Book Value 36.07
NSE Code JAGSNPHARM
Dividend Yield % 1.03
Market Cap 16142.65
P/E 29.16
EPS 8.32
Face Value 2  
Description ( As On March 2025 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter  2  16366035  24.65  16366035  
  Foreign Promoter  3  28638750  43.13  28638750  
  Total Promoter  5  45004785  67.78  45004785  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI          
  FI/Bank/Insurance  2  2000  0    
  Govt          
  FII          
  Other  11  1396798  2.1  1396798  
  Total Institutions  13  1398798  2.1  1398298  
 Non-Institution          
  Bodies Corporate  114  1746195  2.63  1743995  
  Individuals          
  NRIs/OCBs  294  387868  0.58  387868  
  Others  20659  17860984  26.9  17370180  
  Total Non-Institution  21067  19995047  30.11  19502043  
Total Non Promoter  21080  21393845  32.22  20900341  
          
  Depository Receipts          
          
Grand Total  21085  66398630  100  65905126  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.